Literature DB >> 11198308

Cardiac surgery in patients infected with human immunodeficiency virus.

C Abad1, M A Cárdenes, P C Jiménez, M V Armas, P Betancor.   

Abstract

From January 1991 through December 1999, 5 consecutive patients who were infected with human immunodeficiency virus presented in need of cardiac surgery. All were men; the median age was 44 years. Two of them presented with mitral and aortic infectious valve endocarditis, 1 with tricuspid endocarditis, 1 with prosthetic valve endocarditis, and 1 with pericarditis and pericardial tamponade. Under cardiopulmonary bypass, the 4 patients with endocarditis underwent these procedures: mitral and aortic valve replacement (2), tricuspid valve replacement (1), and aortic valve replacement (reoperation) and concomitant repair of a mycotic ascending aortic aneurysm (1). In the patient who had pericardial effusion, subxifoid pericardiostomy and drainage were performed, and a pericardial window was created. There was no intraoperative mortality. The patient with pericardial effusion died 8 days after surgery; he was in septic shock and had multiple organ failure. Two deaths occurred at 2 and 63 months, due to hemoptysis and sudden death, respectively. The 2 patients who underwent double valve replacement are alive and in good condition after a median follow-up of 71 months. Cardiac surgery is indicated in selected patients infected by the human immunodeficiency virus. These patients are frequently drug abusers or homosexual. Valvular endocarditis is the most common finding. Hospital morbidity and mortality rates are higher than usual in this group of patients.

Entities:  

Mesh:

Year:  2000        PMID: 11198308      PMCID: PMC101104     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  21 in total

1.  Coronary artery bypass grafting in patients with human immunodeficiency virus.

Authors:  D R Flum; D H Tyras; M K Wallack
Journal:  J Card Surg       Date:  1997 Mar-Apr       Impact factor: 1.620

2.  Operation for infective endocarditis: results after implantation of mechanical valves.

Authors:  R Bauernschmitt; H G Jakob; C F Vahl; R Lange; S Hagl
Journal:  Ann Thorac Surg       Date:  1998-02       Impact factor: 4.330

3.  Cardiac tamponade in patients infected with HIV. A report from an inner-city hospital.

Authors:  T Kwan; M M Karve; O Emerole
Journal:  Chest       Date:  1993-10       Impact factor: 9.410

4.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

Authors:  F J Palella; K M Delaney; A C Moorman; M O Loveless; J Fuhrer; G A Satten; D J Aschman; S D Holmberg
Journal:  N Engl J Med       Date:  1998-03-26       Impact factor: 91.245

5.  Total aortic arch replacement by a cryopreserved aortic homograft.

Authors:  C Abad; A Hurle; J Feijoo; J Gomez-Marrero; A Abdallah
Journal:  Eur J Cardiothorac Surg       Date:  1995       Impact factor: 4.191

6.  Allograft replacement of the aortic valve for active endocarditis.

Authors:  J S Ladowski; W P Deschner
Journal:  J Cardiovasc Surg (Torino)       Date:  1996-12       Impact factor: 1.888

7.  Cardiac surgery in patients with human immunodeficiency virus infection: indications and results.

Authors:  M Sousa Uva; V A Jebara; J N Fabiani; S M Castel; C Acar; P Grare; J C Dib; A Deloche; A Carpentier
Journal:  J Card Surg       Date:  1992-09       Impact factor: 1.620

8.  Endocarditis in intravenous drug addicts and HIV infected patients: possibilities and limitations of surgical treatment.

Authors:  T Carrel; A Schaffner; P Vogt; A Laske; U Niederhäuser; J Schneider; M Turina
Journal:  J Heart Valve Dis       Date:  1993-03

9.  Cardiac surgery in HIV-positive intravenous drug addicts: influence of cardiopulmonary bypass on the progression to AIDS.

Authors:  M Lemma; P Vanelli; L Beretta; M Botta; A Antinori; C Santoli
Journal:  Thorac Cardiovasc Surg       Date:  1992-10       Impact factor: 1.827

10.  Surgery and human immunodeficiency virus infection: indications, pathologic findings, risks, and risk prevention.

Authors:  E C Klatt
Journal:  Int Surg       Date:  1994 Jan-Mar
View more
  4 in total

1.  Infective Endocarditis in Intravenous Drug Abusers.

Authors:  José M. Miró; Asuncion Moreno; Carlos A. Mestres
Journal:  Curr Infect Dis Rep       Date:  2003-08       Impact factor: 3.725

2.  Delayed esophageal perforation secondary to thoracic aortic aneurysm rupture in a patient with human immunodeficiency virus infection.

Authors:  Tatsuichiro Seto; Tamaki Takano; Kazunori Komatsu; Yoshinori Ohtsu; Takamitsu Terasaki; Yuko Wada; Daisuke Fukui; Shoichiro Koike; Jun Amano
Journal:  Ann Vasc Dis       Date:  2014-06-03

3.  Acute systemic inflammatory response after cardiac surgery in patients infected with human immunodeficiency virus using clinical and inflammatory markers.

Authors:  Mawande Ke Gojo; Rosaley Prakaschandra
Journal:  Afr Health Sci       Date:  2017-09       Impact factor: 0.927

4.  The presence of cardiotropic viral genomes is not increased in atrial tissue of atrial fibrillation patients.

Authors:  L Wu; R W Emmens; J van Wezenbeek; W Stooker; C P Allaart; A B A Vonk; A C van Rossum; K C Wolthers; H W M Niessen; P A J Krijnen
Journal:  Neth Heart J       Date:  2022-01-31       Impact factor: 2.854

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.